2023 ´ç´¢º´ÄáÆϺ´ Á¦1ȸ ½ÉÆ÷Áö¿ò : 2023-03-05±³À°ÀÏÀÚ : 2023-03-05
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2023 ´ç´¢º´ÄáÆϺ´ Á¦1ȸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï 3¸¸¿ø/ÇöÀåµî·Ï 4¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-05 ´ë°´ç 09:00~09:25 Pathophysiology of Diabetic Kidney Disease ±è¿¹´Ï(Ä«Å縯ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 09:25~09:50 Diabetic Kidney Disease - Real World Data ±èÇü¿ì (¿¬´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 09:50~10:10 Diabetic Kidney Disease - cohort study ÇÑ»ó¿±(ÀÎÁ¦ÀÇ´ë ½ÅÀå³»°ú)
Åä·Ð 03-05 ´ë°´ç 10:10~10:30 Panel Discussion ¹®ÁÖ¿µ, ±è¿ø, ¹ÚÈƼ®, ±¸¼ö°æ(°æÈñÀÇ´ë ½ÅÀå³»°ú, ÀüºÏÀÇ´ë ½ÅÀå³»°ú, °¡Å縯ÀÇ´ë ½ÅÀå³»°ú, ±¹¸³º¸°Ç¿¬±¸¿ø)
±³À°½Ã°£ 03-05 ´ë°´ç 10:30~10:55 Diabetic Kidney Disease new advances from randomized controlled trial ÀÌÀº¿µ(¼øõÇâÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 10:55~11:20 Diabetic Kidney Disease current guidelines ±èÁ°æ(ÇѸ²ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 11:20~11:45 Diabetic Kidney Disease new potential therapeutics Â÷´ë·æ(°í·ÁÀÇ´ë ½ÅÀå³»°ú)
Åä·Ð 03-05 ´ë°´ç 11:45~12:10 Panel Discussion ¼Û»óÇå, ±èÁ°æ, ÀÌÁ¤È¯, À̼ҿµ(ºÎ»êÀÇ´ë ½ÅÀå³»°ú, ÇѸ²ÀÇ´ë ½ÅÀå³»°ú, ¼¿ïÀÇ´ë ½ÅÀå³»°ú, Â÷ÀÇ´ë ½ÅÀå³»°ú)
½Ä»ç 03-05 ´ë°´ç 12:10~13:10 Lunch ()
±³À°½Ã°£ 03-05 ´ë°´ç 13:10~13:30 Diabetes Mellitus control in chronic kidney disease besides sglt2i/GLP1RA ±èÇýÁø(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 13:30~13:50 Diabetes Mellitus foot ÃÖ¿µ¶ô(¿ï»êÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 13:50~14:10 Diabetes Mellitus retinopathy º¯¼®È£(¿¬¼¼ÀÇ´ë ¾È°ú)
Åä·Ð 03-05 ´ë°´ç 14:10~14:30 Panel Discussion À¯ÅÂÇö, ¹Ú»ï¿¤, ¹Ú¼±Èñ, Áø±Ôº¹(¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú, ¼øõÇâÀÇ´ë ½ÅÀå³»°ú, °æºÏÀÇ´ë ½ÅÀå³»°ú, °è¸íÀÇ´ë ½ÅÀå³»°ú)
ÈÞ½Ä 03-05 ´ë°´ç 14:30~14:45 Coffee Break ()
±³À°½Ã°£ 03-05 ´ë°´ç 14:45~15:10 Diabetic KetoAcidosis in SGLT2i ¹®ÁÖ¿µ(°æÈñÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 15:10~15:35 Diabetes Mellitus nephropathy biopsy ÀÓ¹üÁø(¿¬´ëÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 03-05 ´ë°´ç 15:35~16:00 Continuous Glucose Monitoring System ¹®¼±ÁØ(¼º±Õ°üÀÇ´ë ³»ºÐºñ³»°ú)